State Tobacco Monopoly Administration Releases Typical Cases of E-Cigarette Law Enforcement

Nov.07.2024
State Tobacco Monopoly Administration Releases Typical Cases of E-Cigarette Law Enforcement
The State Tobacco Monopoly Administration has strengthened e-cigarette regulation by releasing three typical cases to intensify the crackdown on illegal activities within the industry.

2Firsts Reprinted and Translated from the State Tobacco Monopoly Administration

 

This year, tobacco monopoly administrative departments at all levels have resolutely implemented the decisions and directives of the Central Committee of the Communist Party and the State Council, strengthening the full-chain regulation of e-cigarettes.

 

They have taken strong action against illegal and non-compliant e-cigarette activities, investigating and addressing administrative cases in accordance with the law, while continuously working to purify the market order and environment for e-cigarettes. To maximize their deterrent effect, the State Tobacco Monopoly Administration has released three typical cases of e-cigarette law enforcement.

 

 

Zhejiang Mirui Sales of Illegally Manufactured E-Cigarette Products

 

 

From January 2024 until the case was discovered, Zhejiang Mirui Electronic Technology Co., Ltd. (e-cigarette brand holder, tobacco monopoly manufacturing license number: 7133020055, hereinafter referred to as Zhejiang Mirui) repeatedly instructed Shenzhen Langyou Biotechnology Co., Ltd. (a vaporizer production company, tobacco monopoly manufacturing license number: 4144030089, hereinafter referred to as Shenzhen Langyou) to add ingredients to domestic e-cigarette products, such as the "MR Miroo - Meteor Disposable E-Cigarette (Wu Ti)," that were not included in the technically reviewed formula.

 

This resulted in discrepancies between the actual products and the information approved through the technical review, constituting the sale of illegally produced e-cigarette products. In accordance with relevant laws and regulations, Zhejiang Mirui was ordered to cease selling the products, confiscate the illegal gains, and pay a fine of 1.0012 million yuan. Shenzhen Langyou has been dealt with in a separate case.

 

 

Shenzhen Bode Sales of Illegally Manufactured E-Cigarette Products, Operating Outside the Permitted Scope of Vaporizer Production

 

 

From January 2024 until the case was discovered, Boulder (Shenzhen) Technologies, Inc. (e-cigarette brand holder, tobacco monopoly manufacturing license number: 7144030063, hereinafter referred to as Shenzhen Boulder) added ingredients to domestic e-cigarette products like the "Bode Boulder - Classic Series - Jade Dragon Snow Mountain" that were not included in the technically reviewed formula. This led to discrepancies between the products and the approved technical review information, constituting the sale of illegally produced e-cigarette products. 

 

Additionally, Shenzhen Boulder did not possess the qualification to produce vaporizers and, from October 2022 to May 2024, it produced and exported vaporizers, thus engaging in business activities outside its permitted scope. In accordance with relevant laws and regulations, Shenzhen Boulder was ordered to stop selling the related e-cigarette products, fined 3.1514 million yuan, publicly destroyed the illegally sold e-cigarette products, suspended production and business activities for two months, and underwent business rectification.

 

 

Shenzhen Mevol Sales of Illegally Manufactured E-Cigarette Products

 

 

From November 2023 to February 2024, Shenzhen Mevol Chuangxin Technology Co. (e-cigarette brand holder, tobacco monopoly manufacturing license number: 7144030126, hereinafter referred to as Shenzhen Mevol) knowingly sold e-cigarette products such as the "Miwo Mevol-Go·Sangyu Muyu," despite discrepancies between the products and those approved through technical review. 

 

This constitutes the sale of illegally manufactured e-cigarette products. In accordance with relevant laws and regulations, Shenzhen Mevol was ordered to stop selling the related e-cigarette products, fined 805,200 yuan, and publicly destroyed the illegally sold products.

 

 

Case Warnings

 

 

In order to prevent the inducement of minors to use e-cigarettes and to safeguard public health and safety, the "E-Cigarette Management Measures" explicitly stipulate that e-cigarette products not approved through technical review must not be marketed or sold. Products available on the market must align with the information of those that have passed the technical review.

 

The companies involved in these cases, motivated by profit, have violated national laws, regulations, and regulatory provisions by introducing ingredients outside the approved technical formulas into domestic e-cigarette products. As a result, these products did not conform to the approved specifications.、

 

Such actions pose a significant risk to public health, particularly the health of minors, disrupt the integrity of the e-cigarette market, and necessitate legal investigation and appropriate penalties. The typical cases published in this instance underscore the steadfast commitment of the tobacco monopoly administrative authorities to enforce e-cigarette regulation in strict accordance with the law.

 

Moving forward, tobacco monopoly administrative departments at all levels will diligently fulfill their responsibilities in e-cigarette regulation, intensify oversight, and actively investigate similar cases. They will further strengthen legal protections against the harmful effects of e-cigarettes on minors, safeguard public health, and expedite the establishment of a robust quality assurance system for e-cigarette products.

 

The responsibility for product quality will be firmly placed on the producers of e-cigarettes, with stringent supervision over the establishment and implementation of internal quality control management systems. Additionally, efforts will be made to enhance legal education and policy dissemination, guiding e-cigarette operators to comply with laws and regulations. In doing so, the regulatory framework governing e-cigarettes will continue to be strengthened, ensuring the ongoing consolidation of legal and regulatory achievements in e-cigarette governance.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10
Reynolds Puts Nearly 183,000 U.S. Contracted Outlets Under Age-Verification Rules, Covering 94% of Volume — Can It Shift an Unauthorized Vape Market?
Reynolds Puts Nearly 183,000 U.S. Contracted Outlets Under Age-Verification Rules, Covering 94% of Volume — Can It Shift an Unauthorized Vape Market?
Reynolds American says nearly 183,000 U.S. retail outlets are under contract, with its Retail Marketing Plan Contract covering about 94% of company volume and requiring point-of-sale age verification. The company combines those contracts with We Card, TruAge, NACS-linked infrastructure and POS integration, while enhanced Vuse Pro retail rules add ID scanning, purchase limits and stronger underage-sales accountability. The initial Vuse Pro rollout targets about 50,000 stores. The system is taking shape as unauthorized vapor products remain dominant in parts of the U.S. market: a 2026 study estimated they accounted for 69.4% of tracked brick-and-mortar e-cigarette dollar sales in December 2025.
Special Report
Oct.15
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Imperial Brands' acquisition of Swedish Helwit owner Yoik Group AB has highlighted the professional-services firms supporting cross-border oral nicotine M&A. Latham & Watkins and KPMG advised Imperial, while PwC and TM & Partners advised Yoik. KPMG also appeared on Imperial's acquisition of Black Buffalo earlier in 2026, while PwC played an extensive role in KT&G's acquisition of Swedish nicotine-pouch company Another Snus Factory. Imperial's public disclosures put the global modern oral nicotine delivery market at approximately £8.8 billion in retail sales and 23.5 billion pouches in 2024
Sep.20
Australian Coalition Unveils Illicit Tobacco Plan With 80% Excise Cut and Legal, Taxed Vapes and Nicotine Pouches
Australian Coalition Unveils Illicit Tobacco Plan With 80% Excise Cut and Legal, Taxed Vapes and Nicotine Pouches
Australia’s Coalition has unveiled a national illicit-tobacco policy that would cut tobacco excise by 80% and create legal, regulated and taxed adult markets for vaping products and nicotine pouches if it wins government. The plan proposes an excise of A$0.50 per millilitre of e-liquid and A$0.025 per milligram of nicotine in pouches, alongside A$200 million in additional enforcement and a A$60 million three-year public-awareness campaign. The Coalition says the package would narrow the price advantage of illicit products and undermine organised crime, while Labor and public-health groups warn that dramatically cheaper cigarettes could reverse long-term declines in smoking.
Sep.03
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26